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Abstract
Background We retrospectively evaluated the relationship between cytokine gene polymorphisms and development of postop-
erative pneumonia after esophagectomy.
Methods In 120 patients who underwent esophagectomy, serum samples were obtained to measure levels of serum interleukin
(IL)-6 and IL-10 at four time points (preoperatively, postoperative day (POD)0, POD1, and POD3). DNA extracted from
peripheral blood in all patients was analyzed to determine polymorphisms of cytokines such as tumor necrosis factor-α -1031 T/
C, IL-1β -511C/T, IL-6 -634C/G, and IL-10 -819 T/C.
Results Postoperative pneumonia arose in 34 patients (28.3%). Perioperative serum IL-10 levels were significantly higher for IL-
10 -819 C/T+C/C genotypes than for T/T genotypes (POD0 16.7±2.84 vs. 8.54±0.87 pg/ml, p=0.0002; POD1 14.0±2.64 vs.
8.8±0.87 pg/ml, p=0.0143; POD3 8.9±2.67 vs. 4.4±0.52 pg/ml, p=0.0076). The frequency of the IL-10 -819 T/T genotype was
significantly higher in patients with postoperative pneumonia than in patients without pneumonia (p=0.0323). Multivariate
analysis of factors such as sex, smoking, length of operation, field of lymph node dissection, and IL-10 polymorphism identified
IL-10 polymorphism as independent predictor of postoperative pneumonia.
Conclusions Patients with IL-10 -819 T/T genotype may be at high risk for postoperative pneumonia after esophagectomy.
Keywords IL-10 polymorphism . Postoperative pneumonia .
Esophagectomy
Introduction
Surgery for esophageal cancer is one of the most invasive
gastrointestinal surgeries,1, 2 and perioperative mortality rates
remain in the range of 3–10 %.3
–5 In the case of esophageal
cancer, marked elevations in cytokine levels are observed
perioperatively, inducing a systemic inflammatory response
syndrome (SIRS).6, 7 Such hypercytokinemia produces exces-
sive stress and may trigger postoperative complications.8 The
lungs is one of the main organs of neutrophil sequestration
under conditions of SIRS.9
–12 Abe et al. reported that trans-
thoracic esophagectomy causes an increase in interleukin (IL)-
6 production from bronchial and alveolar epithelial cells lining
the airway, and local response of lung tissue may be one
source of increased serum IL-6 after esophagectomy in
humans.13 The clinical effects of an immune response are
orchestrated by numerous pro-inflammatory, inflammatory,
and anti-inflammatory cytokines. Tumor necrosis factor
(TNF)-α is a major mediator and amplifier of immune
responses to infectious challenges. Azim et al. recently
reported that the TNF-α -308 polymorphism contributes
to infectious complications after esophagectomy.14
Moreover, associations between infection and genetic
polymorphisms have been reported for other cytokines,
including IL-1β, IL-6, and IL-10.15
–18 These findings
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suggest that patient genotype may influence susceptibil-
ity to postoperative infection.
We have a considerable interest in whether factors such as
these polymorphisms might affect the postoperative infection,
particularly in terms of the effects on postoperative pneumo-
nia. We selected TNF-α, IL-1β, IL-6, and IL-10 as represen-
tative pro-inflammatory, inflammatory, and anti-inflammatory
cytokines and investigated the gene promoter polymorphisms
of TNF-α -1031 T>C (rs1799964), IL-1β -511 T>C
(rs3087258), IL-6 -634G>C (rs1800796), and IL-10 -
819 T>C (rs1800871); all of which have been reported to
influence cytokine production.18
–22 The purpose of this study
was to assess whether cytokine promoter gene polymorphisms
are associated with the following: (1) perioperative cytokine




This was a retrospective cohort study that included patients
treated for esophageal cancer between 1997 and 2011.
Participants comprised 120 consecutive Japanese patients
(105 men and 15 women) with thoracic esophageal cancer
who underwent curative esophagectomy and reconstruction
with gastric mobilization via a posterior mediastinal or
retrosternal route by right posterolateral thoracotomy and
laparotomy consecutively in the Department of Digestive
Surgery and Surgical Oncology at Yamaguchi University
Graduate School of Medicine. These patients underwent dis-
section of two (mediastinal and abdominal) or three (bilateral
neck, mediastinal, and abdominal) lymph node fields. Patients
who received neoadjuvant treatment or underwent reconstruc-
tion with small intestine or colon mobilization were excluded.
We introduced thoracoscopic procedures in a prone position
from 2008 and excluded these procedures from the present
study. In all cases, diagnoses of esophageal squamous cell
cancer were confirmed preoperatively on the basis of histo-
pathological reports. The clinicopathological definition of
thoracic esophageal cancer was based on the International
Union against Cancer tumor-node-metastasis (TNM) classifi-
cation of malignant tumors (6th edition). Written informed
consent was obtained from all study patients. The study pro-
tocol was approved by the Institutional Review Board for the
Use of Human Subjects at Yamaguchi University Graduate
School of Medicine.
Perioperative Management
We performed perioperative management as follows. At the
first visit to our hospital, all patients were instructed to quit
smoking and respiratory rehabilitation was started at the same
time. As prophylactic antibiotics, patients received cefazolin
1 g by intravenous infusion for 30 min before the operation.
An additional dose was administered if the operation was
prolonged beyond 3 h. Patients received the same antibiotics
plus further treatment at 12-h intervals, for a total of 5 days.
For nutritional support, enteral nutrition was provided via
jejunostomy from 6 h postoperatively, and the dose was
increased step-by-step to 2,000 kcal/day up to postoperative
day (POD) 7. All patients were admitted to the intensive care
unit and placed on prophylactic mechanical ventilation. The
timing of extubation was decided according to the results of
bronchoscopy, blood gas analysis, and chest radiography. The
criteria for extubation were as follows: (1) arterial oxygen
pressure >100 mmHg with inspired fraction of oxygen
(FiO2) 0.4 and (2) absence of atelectasis on bronchoscopic
view or radiography.
Postoperative Complications
Postoperative complications were defined as follows.
Postoperative pneumonia was diagnosed by the presence of
pyrexia >38 °C within 2 weeks postoperatively and either
positive sputum cultures or clear clinical or radiological evi-
dence of consolidation. Anastomotic leakage was diagnosed
by gastrography and clinical features. Postoperative wound
infection was defined as a systemic response to the presence of
an infectious agent supported by clinical and laboratory evi-
dence, where laboratory evidence means positive culture re-
sults. Cardiac complications including arrhythmia, angina, or
heart failure were diagnosed by a cardiologist.
Serum Cytokines
Serum samples were obtained at four time points (preopera-
tively, end of the operation (POD0), POD1, and POD3) and
stored at −80 °C until use. Serum IL-6 and IL-10 levels were
measured using commercially available enzyme-linked im-
munosorbent assay kits (BioSource International, Camarillo,
CA). Samples were prepared and tested in duplicate according
to the protocol recommended by the manufacturer.
DNA Specimens and Genotyping
For DNA analysis, 7 ml of peripheral blood was obtained
from all patients. DNA was isolated by a conventional NaI
method and stored at 4 °C.23 All polymorphisms were identi-
fied with the tetra-primer amplification refractory mutation
system-polymerase chain reaction (ARMS-PCR), and details
of primers and PCR conditions have been described in the
literature.24
–26
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Statistical Analysis
Data are expressed as mean values±standard error and were
analyzed using the Mann-Whitney U test. Categorical data
were analyzed using the χ2 test or Fisher’s exact test.
Differences in genotype frequency were analyzed using the
χ2 test or Fisher’s exact test of independence, with which,
each of the genotype frequencies was evaluated to determine
whether it was consistent with expected Hardy-Weinberg
proportions. Because homozygotes for the rare allele were
too few to perform a 2×3 χ2 test or Fisher’s exact test,
homozygotes of the dominant alleles and variant carriers were
compared by 2×2 test. Variables with a p<0.2 in the univar-
iate analysis that were potentially predictive of postoperative
pneumonia were then entered into the multivariate logistic
regression model. Odds ratio (OR) and 95 % confidence
interval (CI) were also calculated. A value of p<0.05 was
considered statistically significant. All analyses were per-
formed using StatView version 5.0 statistical software (SAS
Institute, Cary, NC).
Results
In all 120 patients studied, the frequency of postoperative
pneumonia was 28.3 % (34 of 120 patients). In terms of other
complications, 14 patients (11.7 %) developed wound infec-
tion, 8 patients (6.7%) developed anastomotic leakage, and 25
patients (20.8 %) developed cardiac complications.
Perioperative patient- and tumor-related factors and other
complications were compared between groups with and with-
out postoperative pneumonia (Table 1). The proportion of
males was significantly higher among patients with pneumo-
nia (97.1 %) than among patients without pneumonia (82.6 %;
Table 1 Patient characteristics in
the two groups
Data are presented as
mean+standard error or absolute
numbers
FEV forced expiratory volume,
CRPC-reactive protein,UICC In-
ternational Union Against Cancer
Pneumonia+(n=34) Pneumonia−(n=86) p value
Age 63.7±8.9 63.0±9.2 0.337
Gender
Male 33 71
Female 01 15 0.0384
Body mass index (kg/m2) 21.0±3.0 21.1±3.0 0.954
Smoking
Yes 32 71
No 02 15 0.147
FEV1.0 % 73.2±12.2 73.1±8.8 0.592




Lower 09 33 0.465
UICC stage (pathological)
I and II 21 50
III and IV 13 36 0.716
Length of operation (min) 463±100 433±99 0.0679
Blood loss (g) 820±913 548±267 0.283
Field of lymph node dissection
2 (mediastinum and abdomen) 22 68
3 (bilateral neck, mediastinum, and abdomen) 12 18 0.102
Wound infection
Yes 5 09
No 29 77 0.536
Anastomotic leakage
Yes 03 05
No 31 81 0.686
Cardiac complications
Yes 09 16
No 25 70 0.339
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p=0.0384). The proportions of smoking, 3-field lymph node
dissection, and the length of operation tended to be higher
among patients with pneumonia than among patients without
pneumonia (p=0.147, p=0.102, and p=0.0679, respectively).
No relationship was seen between perioperative serum IL-6
levels and polymorphisms (Fig. 1). Perioperative serum IL-10
levels were significantly higher for IL-10 -819 C/T+C/C
genotypes than for T/T genotypes (POD0 16.7±2.84 vs.
8.54±0.87 pg/ml, p=0.0002; POD1 14.0±2.64 vs. 8.8±
0.87 pg/ml, p=0.0143; POD3 8.9±2.69 vs. 4.4±0.52 pg/ml,
p=0.0076) (Fig. 2).
Among the cytokine promoter gene polymorphisms ana-
lyzed, a significant association with pneumonia was found for
IL-10 -819 T/C. The frequency of the IL-10 -819 T/T geno-
type was significantly higher in patients with pneumonia than
in those without pneumonia (p=0.0323) (Table 2).
Although no relationship was seen between postoperative
serum IL-10 levels and Il-10 polymorphisms in patients with
pneumonia, these levels were significantly higher for IL-10 -
819 T/C+C/C genotypes than for T/T genotypes in patients
without pneumonia (Table 3).
Clinicopathological variables, including sex (male vs. fe-
male), smoking (yes vs. no), length of operation, field of
lymph node dissection (three vs. two), and IL-10 -819 poly-
morphism (T/T vs. C/T+C/C) were entered into a multivariate
logistic regression model to identify factors influencing pneu-
monia (Table 4). Only IL-10 -819 polymorphism was signif-
icantly associated with pneumonia (p=0.0334, OR=2.68,
95 % CI=1.08–6.67).
Discussion
This study revealed that IL-10 -819 polymorphism is associ-
ated with postoperative pneumonia in Japanese patients with
esophageal cancer. The IL-10 -819 TT genotype is related to
lower perioperative production of serum IL-10 level. No
associations with any other cytokine polymorphism for
Fig 1 Pre- and postoperative serum levels of interleukin (IL)-6. The
relationship between polymorphism of the cytokine genes (tumor necro-
sis factor (TNF)-α -1031 T/C, IL-1β -511C/T, IL-6 -634C/G, IL-10 -
819 T/C) and IL-6 level in 120 patients after esophagectomy. Solid circles
indicate wild-type polymorphism, open circles indicate variant-type poly-
morphism. Values are expressed as mean±standard error. Statistically
significant according to the Mann-Whitney U test. IL interleukin, TNF
tumor necrosis factor, POD postoperative day
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TNF-α, IL-1β, or IL-6 were evident. Presence of the IL-10 -
819 TT genotype seems to confer lower IL-10 release in
response to surgical stress and an increased risk of postoper-
ative pneumonia.
Under highly inflammatory conditions such as following
esophagectomy, a genotype associated with high anti-
inflammatory response may be protective against the devel-
opment of postoperative respiratory inflammation. IL-10 is a
potent endogenous anti-inflammatory cytokine that decreases
lung inflammation, partly on the basis of TNF-α and IL-1β.27
Alveolar macrophages produce significant amounts of IL-
10.28, 29 Morita reported that IL-10 production after rat thora-
cotomy was higher from the collapsed lung than from the
uncollapsed lung, possibly reflecting suppression of IL-6 pro-
duction from the collapsed lung.30 These findings are support-
ed by the clinical observation that decreased IL-10
Fig 2 Pre- and postoperative serum levels of interleukin (IL)-10. The
relationship between polymorphism of cytokine genes (tumor necrosis
factor (TNF)-α -1031 T/C, IL-1β -511C/T, IL-6 -634C/G, IL-10 -819 T/
C) and IL-10 level in 120 patients after esophagectomy. Solid circles
indicate wild-type polymorphism, open circles indicate variant-type
polymorphism. Values are expressed as mean±standard error. Statistically
significant according to the Mann-Whitney U test. *p=0.0002;
#p=0.0143; $p=0.0076. IL interleukin, TNF tumor necrosis factor, POD
postoperative day
Table 2 Genotype distribution in
the postoperative pneumonia
TNF tumor necrosis factor, IL
interleukin
Cytokine polymorphism Pneumonia+(n=34) Pneumonia−(n=86) p value
TNF-α -1031 T/T 21 62 0.27
T/C+C/C 13 24
IL-1β -511 C/C 08 26 0.463
C/T+T/T 26 60
IL-6 -634 G/G 20 47 0.678
G/C+C/C 14 39
IL-10 -819 T/T 22 37 0.0323
T/C+C/C 12 49
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concentration in bronchoalveolar lavage fluid is associated
with worse outcomes in patients with the acute respiratory
distress syndrome.31 IL-10 therapy increased survival both in
a rabbit Pseudomonas aeruginosa pneumonia model and in a
murine pneumococcal pneumonia model.32 Those results in-
dicate that IL-10 is a key regulator of the degree of inflamma-
tion in the setting of acute lung infection or inflammation.
The current finding that the high IL-10-producing -819C
allele is protective against postoperative respiratory inflam-
mation following esophagectomy is consistent with the role of
intense inflammation. Lowe et al. reported that the IL-10 -592
CC polymorphism was associated with higher IL-10 release
under lipopolysaccharide stimulation and lower mortality in
critically ill patients.20 Similar frequencies were obtained for -
819 T/C and -592 A/C in all types of participants, indicating
complete linkage.33 Those findings are consistent with our
own results. However, in critically ill patients with sepsis, the
mortality rate was significantly higher in patients with the -
592 CC genotype than in those with the -592 AA genotype.33
The overall balance between pro- and anti-inflammatory re-
sponses is important in response to injury or surgery. In
patients with sepsis, a genotype associated with high IL-10
production may lead to greater immunosuppression, resulting
in more severe disease burden and outcomes. In contrast, the
present findings were obtained following esophagectomy. In
such cases, a genotype associated with high IL-10 may have
beneficial modulating effects. The notion that a high IL-10-
producing -819 C allele may not be universally detrimental
appears reasonable.
Azim et al. reported that not IL-10 -819 T/C but TNF-α-
308G/A polymorphism contributes to infectious complica-
tions after esophagectomy.14 That result differs from the find-
ings of the present study. However, the frequency of the -308
A allele for TNF-α is much lower in Japanese populations
(1.1–1.3 %) than in Caucasians (10–18 %).33
–36 Furthermore,
the frequency of the -819 C allele of IL-10 in Japanese (30.5–
33.6 %) was lower than in Caucasians (79–82 %).20, 33, 37
These results suggest that considering the influence of ethnic
differences in gene polymorphism may be important. Further
studies on gene polymorphisms in different ethnicities are
needed to allow tailoring of specific therapies. Identifying
IL-10 polymorphisms in patients prior to esophagectomy
may influence management decisions where controversy cur-
rently exists, such as the use of other therapeutic strategies.
For example, whether steroids should be used to treat patients
perioperatively remains unresolved.38 Some patients may
benefit, while others may not, depending on individual geno-
types. Genotyping this IL-10 polymorphism in patients fol-
lowing esophagectomymay allow better risk stratification and
tailoring of specific therapies to different risk groups.
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